Showing posts with label antibiotics. Show all posts
Showing posts with label antibiotics. Show all posts

Tuesday, 29 June 2010

Global initiatives formulated for tackling supply of illegal drugs

A joint operation was recently exercised to curb the supply of dangerous and illegal medicines.
This operation was made to demonstrate the dangers of buying drugs online and received significant support from the Permanent Forum on International Pharmaceutical Crime (PFIPC) the World Customs Organization, the UK's Medicines and Health Care products Regulatory Agency (MHRA), the US Food and Drug Administration (FDA) and Immigration and Customs Enforcement (ICE), the Royal Canadian Mounted Police, and Health Canada.
During the operation, Internet monitoring revealed 751 websites engaged in illegal activity, including offering controlled or prescription only drugs, 72 of which have now been taken down. In addition, more than 16,000 packages were inspected by regulators and customs, 995 packages were seized and nearly 167,000 illicit and counterfeit pills - including antibiotics, steroids and slimming pills, confiscated.
Twenty-two individuals are currently under investigation for a range of crimes including illegally selling and supplying unlicensed or prescription-only medicines.
"As the very positive results of this global effort are made public, INTERPOL and its member countries will prove again that the Internet is not an anonymous safe haven for those who use it for criminal purposes. We hope that by raising public awareness about the dangers of illegal internet pharmacies, consumers will exercise greater care when purchasing medicines on the Internet," added Secretary General Noble.
"Our thanks go to the police, customs and regulatory officials in the 24 participating countries as well as to our partner international organizations such as the World Health Organization's IMPACT, the World Customs Organization and Universal Postal Union whose tireless efforts and dedication have made Operation Pangea II such a success," Noble concluded.
Operation Pangea II was coordinated by INTERPOL and the World Health Organization's International Medical Products Anti-Counterfeiting Taskforce (IMPACT). The week-long initiative was highlighted by a series of arrests and seizure of thousands of potentially harmful medical products.

Thursday, 24 June 2010

Identification of breast cancer type without lump

Lumps in the breast region are possible signs of breast cancer but most of us are caught unaware about a breast cancer type, inflammatory breast cancer, which is not characterized by a lump.
This cancer type warrants urgent diagnosis so that life of afflicted patients could be saved, according to Sofia Merajver, M.D., Ph.D., co-director of the Breast Oncology Program at the University of Michigan Comprehensive Cancer Center.
Inflammatory breast cancer is a very aggressive type of cancer in which the cancerous cells move rapidly throughout the breast and clog the lymph vessels in the skin, causing the breast to look swollen, red, itchy or inflamed. It's often mistaken for a rash or infection and many women are initially treated with antibiotics or steroids.
“There are many options for treating this disease. In many cases, the treatment is going to be on and off for life. There will be times of remission, but this is a serious disease that has a high chance of recurring,” says Merajver, a professor of internal medicine at the U-M Medical School.
About inflammatory breast cancer
* Represents 3 percent to 6 percent of the 180,000 women diagnosed with breast cancer each year.
* With treatment, 20 percent to 40 percent of patients survive 10 years. This is up from 5 percent to 10 percent 20 years ago.
* Characterized by redness, warmth or an orange-skin appearance on the skin of the breast. A persistent red breast should be biopsied promptly.
* May or may not cause a lump or mass.
* Treatment includes aggressive chemotherapy, followed by surgery and radiation therapy.
Merajver said that the U-M Inflammatory Breast Cancer Clinic would be turning into a clearinghouse for passing information related to tertiary care and advice.

Monday, 12 April 2010

Target discovered for modified antibiotics

Researchers at the Technische Universität München (TUM) have been able to discover a promising target for a new class of antibiotics.

The finding is considered to offer insights on how to handle bacterial stems developing resistance to previously life-saving antibiotics.

Results of the work by involved researchers were presented in an issue of the chemistry journal Angewandte Chemie.

From Sciencedaily.com:

The cells of virtually all life forms synthesize essential natural substances belonging to the class of terpenes and steroids from the small isoprene building blocks dimethylallyl pyrophosphate (DMAPP) and isopentenyl pyrophosphate (IPP). Mammals and a large number of other organisms generate these essential metabolites via the so-called mevalonate pathway. But most human pathogens, including Plasmodium falciparum, have developed an alternate mechanism for producing these important substances. Now, this special pathway may spell doom for those bacteria. The TUM researchers have unraveled the structural basis of the terminal step in bacterial isoprene synthesis. The crucial enzyme has a most unusual structure, similar to a three-leaf clover, and may open a forceful line of attack for custom-tailored antibiotics.

Professor Michael Groll, Dr. Jörg Eppinger and Dr. Tobias Gräwert, biochemists at the Technische Universität München, and their team of researchers, described in detail about the structural basis for new reaction steps critical to microorganisms but playing no relevant role in humans.